Metraipolis › archive › dc_ecd3dbfd269e

Safety and immunogenicity of an adjuvanted human onchocerciasis vaccine candidate, OvMANE1: preclinical evaluation in a mice model — Europe PMC PMID:42382335

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42382335
DOI: 10.1002/cti2.70114
License (as archived): solo-consultazione
Archived: 2026-10-08T02:33:23.834Z
SHA-256 of the archived text: 1c2b1e9f11c786db918180d2e7573c540432599efd18fc79fe6e2f4a6d286ec4
Stable URL of this page: https://metraipolis.com/documento/dc_ecd3dbfd269e

How to cite

Safety and immunogenicity of an adjuvanted human onchocerciasis vaccine candidate, OvMANE1: preclinical evaluation in a mice model — Europe PMC PMID:42382335 — Europe PMC (en), https://europepmc.org/article/MED/42382335 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ecd3dbfd269e (Metraipolis archive dc_ecd3dbfd269e, sha256 1c2b1e9f11c786db918180d2e7573c540432599efd18fc79fe6e2f4a6d286ec4)

BibTeX

@misc{dcecd3dbfd269e,
  title = {Safety and immunogenicity of an adjuvanted human onchocerciasis vaccine candidate, OvMANE1: preclinical evaluation in a mice model — Europe PMC PMID:42382335},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42382335},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ecd3dbfd269e; sha256 1c2b1e9f11c786db918180d2e7573c540432599efd18fc79fe6e2f4a6d286ec4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42382335. Agents can read the archived copy with the MCP tool read_document.